I-PRESERVE Trial Irbesartan in heart failure with preserved EF Co-PIs: Peter Carson and Barry Massie Executive Committee M. Komajda, R. McKelvie, J. McMurray,
HFSA 2010 Comprehensive Heart Failure Practice Guideline Key Recommendations.
Left Ventricular Dyssynchrony and Cardiac Resynchronization Therapy in Heart Failure Airley E. Fish MD Imaging Conference August 19 th 2009.
LV Dssynchrony and Cardiac Resynchronization Therapy in Heart Failure Nisha I. Parikh MD MPH August 13 th 2008.
Trial to Assess Chelation Therapy (TACT) Principal Investigator: Gervasio A. Lamas, MD Mount Sinai Medical Center – Miami Heart Institute Miami Beach FL.
Highlights in ischaemic cardiovascular disease Doc dr Amra Džanković.
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT Systolic Heart failure.
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial
New Trends in Heart Disease
Highlights in ischaemic cardiovascular disease
EXERCISE PRESCRIPTION FOR CHF
Case Study Congestive Heart Failure
